Completed PHASE2 INTERVENTIONAL 3-arm NCT01318252

AL-54478 Proof of Concept Study

Sponsor: Alcon Research

Conditions Ocular Hypertension (OHT) Open-angle Glaucoma (OAG)

Interventions AL-54478 0.005% AL-54478 Vehicle Latanoprost 0.005%

Updated 7 times since 2017 Last updated: Jul 28, 2014 Started: Jun 30, 2011 Primary completion: Oct 31, 2011 Completion: Oct 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Ocular Hypertension (OHT) and Open-angle Glaucoma (OAG), this trial is completed. The trial is conducted by Alcon Research and has accumulated 7 data snapshots since 2011. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Apr 2022 — Jul 2024 [monthly]

Completed PHASE2
Jan 2021 — Apr 2022 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Jun 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Alcon Research

Data source: Alcon Research

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.